308
Participants
Start Date
October 31, 2006
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
Aluminum hydroxide
Adjuvant administered with A/H5N1 vaccine dosages 7.5 mcg and 15 mcg.
Inactivated Vero cell based whole virus influenza A/H5N1
Inactivated Vero cell-grown, whole virus, influenza A/H5N1 vaccine at dosages 7.5 mcg and 15 mcg of hemagglutinin (HA) per 0.5 mL, each dosage with and without aluminum hydroxide adjuvant; 45 mcg HA/0.5 mL without adjuvant.
Placebo
Saline injected into the deltoid muscle. 2 identical dosages will be given approximately 28 days apart.
University of Maryland School of Medicine, Baltimore
Vanderbilt University, Nashville
Baylor College of Medicine, Houston
UCLA Center For Vaccine Research, Torrance
Stanford University, Stanford
National Institute of Allergy and Infectious Diseases (NIAID)
NIH